Søren Nielsen Selected Research

Body Weight (Weight, Body)

1/2020	A new experimental mouse model of water intoxication with sustained increased intracranial pressure and mild hyponatremia without side effects of antidiuretics.
1/2020	Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents.
1/2009	Long-term EGF treatment partially prevents reduction of renal blood flow in response to neonatally induced partial unilateral ureteral obstruction.
2/2007	Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Søren Nielsen Research Topics

Disease

21	Insulin Resistance 04/2024 - 10/2003
20	Ureteral Obstruction 09/2013 - 05/2003
19	Polyuria 10/2014 - 01/2002
16	Obesity 04/2024 - 04/2003
15	Nephrogenic Diabetes Insipidus 10/2014 - 03/2003
14	Neoplasms (Cancer) 11/2022 - 01/2004
13	Type 2 Diabetes Mellitus (MODY) 09/2023 - 09/2008
11	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2004
9	Heart Failure 01/2023 - 01/2002
9	Acidosis 01/2017 - 03/2003
9	Acute Kidney Injury (Acute Renal Failure) 07/2014 - 10/2002
6	Inflammation (Inflammations) 01/2018 - 09/2008
5	Chronic Renal Insufficiency 12/2020 - 11/2010
5	Nephrotic Syndrome (Syndrome, Nephrotic) 09/2013 - 05/2004
5	Malignant Mesothelioma 07/2006 - 01/2004
4	Body Weight (Weight, Body) 01/2020 - 02/2007
4	Hyperinsulinism (Hyperinsulinemia) 01/2016 - 03/2007
4	Ischemia 06/2014 - 08/2004
4	Liver Cirrhosis (Hepatic Cirrhosis) 09/2013 - 03/2003
4	Diabetes Mellitus 05/2008 - 02/2007
4	Ascites 12/2007 - 05/2004
3	Metabolic Diseases (Metabolic Disease) 04/2024 - 01/2008
3	Overweight 04/2024 - 01/2012
3	Carcinoma (Carcinomatosis) 05/2022 - 11/2004
3	Abdominal Obesity 01/2022 - 02/2004
3	Adenocarcinoma 05/2017 - 02/2002
3	Infections 12/2012 - 07/2007
3	Proteinuria 11/2010 - 05/2004
3	Bone Resorption 05/2010 - 02/2009
3	Hydronephrosis 01/2009 - 06/2004
3	Neoplasm Metastasis (Metastasis) 11/2005 - 01/2004
3	Hypercalcemia (Milk Alkali Syndrome) 03/2004 - 01/2002
2	Liver Diseases (Liver Disease) 04/2024 - 12/2023
2	Fatty Liver 01/2023 - 11/2022
2	Dyslipidemias (Dyslipidemia) 11/2022 - 01/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2022 - 01/2018
2	Hyponatremia 01/2020 - 01/2015
2	Non-alcoholic Fatty Liver Disease 10/2018 - 01/2016
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 02/2015
2	Mucositis 01/2018 - 01/2017
2	Starvation 07/2016 - 06/2012
2	Hepatocellular Carcinoma (Hepatoma) 02/2016 - 01/2016

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 09/2023 - 02/2002
22	SodiumIBA 01/2015 - 02/2002
20	Aquaporins (Water Channels)IBA 07/2016 - 12/2002
16	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2003
14	Aquaporin 2IBA 12/2013 - 03/2003
13	Insulin (Novolin)FDA Link 04/2024 - 02/2004
13	LithiumIBA 10/2014 - 12/2003
11	LipidsIBA 11/2022 - 04/2003
11	Messenger RNA (mRNA)IBA 05/2020 - 01/2004
11	Triglycerides (Triacylglycerol)IBA 01/2018 - 01/2007
8	Vasopressins (Vasopressin)IBA 01/2015 - 01/2002
7	Nonesterified Fatty Acids (NEFA)IBA 04/2024 - 08/2010
7	very low density lipoprotein triglycerideIBA 11/2022 - 03/2007
7	AldosteroneIBA 05/2008 - 12/2002
6	salicylhydroxamic acid (SHAM)IBA 12/2020 - 12/2003
6	PalmitatesIBA 10/2018 - 08/2010
5	Glycerol (Glycerine)FDA LinkGeneric 06/2022 - 02/2007
5	AcidsIBA 01/2017 - 08/2008
5	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2015 - 03/2003
5	Epithelial Sodium ChannelsIBA 05/2008 - 11/2005
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
4	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2020 - 07/2007
4	VLDL LipoproteinsIBA 01/2018 - 01/2009
4	Angiotensin IIIBA 01/2015 - 10/2004
4	CytokinesIBA 07/2014 - 04/2009
4	alpha-MSHIBA 04/2010 - 08/2004
4	Adenosine Triphosphatases (ATPase)IBA 12/2009 - 01/2004
4	CalciumIBA 03/2009 - 12/2001
3	fibroblast growth factor 21IBA 04/2024 - 12/2009
3	Metformin (Glucophage)FDA LinkGeneric 09/2023 - 01/2018
3	Estrogen ReceptorsIBA 01/2023 - 11/2004
3	AntibodiesIBA 05/2022 - 09/2003
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2017
3	human ERBB2 proteinIBA 05/2017 - 02/2012
3	Small Interfering RNA (siRNA)IBA 02/2016 - 05/2010
3	Oxygen (Dioxygen)IBA 11/2014 - 01/2009
3	CreatinineIBA 07/2014 - 12/2003
3	Melanocyte-Stimulating Hormones (MSH)IBA 06/2014 - 01/2011
3	Lactic Acid (Lactate)FDA LinkGeneric 12/2012 - 10/2002
3	SymportersIBA 05/2010 - 09/2004
3	Hormones (Hormone)IBA 05/2008 - 07/2003
2	Glucagon (Glukagon)FDA Link 04/2024 - 11/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 11/2005
2	Long Noncoding RNAIBA 10/2023 - 01/2020
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 11/2004
2	SolutionsIBA 01/2020 - 01/2014
2	etomoxirIBA 01/2020 - 01/2018
2	EnzymesIBA 01/2020 - 09/2003
2	Keratins (Keratin)IBA 11/2019 - 01/2016
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2017
2	Testosterone (Sustanon)FDA Link 06/2016 - 05/2013
2	ChemokinesIBA 07/2014 - 06/2014
2	Erythropoietin FDA Link 10/2013 - 08/2004
2	ElectrolytesIBA 09/2013 - 09/2009

Therapy/Procedure

4	Ligation 12/2009 - 02/2002
3	Nephrectomy 12/2020 - 11/2010
2	Therapeutics 12/2022 - 06/2008
2	Radiotherapy 01/2018 - 11/2005